← FDA Drug Approvals (Drugs@FDA)

TICAGRELOR

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PRINSTON INC · Approved 2024-08-16

Drug application

FDA Application #

ANDA208599

Application type

Abbreviated New Drug Application (Generic)

Brand name

TICAGRELOR

Generic name

TICAGRELOR

Active ingredients

TICAGRELOR

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

PRINSTON INC

Manufacturer

Solco Healthcare U.S., LLC

First approval

2024-08-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown